Laxavit 12 ml rect. sol. applic.

Country: Բելգիա

language: անգլերեն

source: AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

active_ingredient:

Docusate Sodium 249,96 mg/12 ml; Glycerol 14,85 g/12 ml

MAH:

Kela Pharma SA-NV

ATC_code:

A06AG10

INN:

Docusate Sodium; Glycerol

dosage:

12 ml

pharmaceutical_form:

Rectal solution

composition:

Docusate Sodium 20.83 mg/ml; Glycerol 1237.17 mg/ml

administration_route:

Rectal use

therapeutic_area:

Docusate Sodium, Incl. Combinations

leaflet_short:

CTI code: 114922-03 - Pack size: 10 x 12 ml - Commercialisation status: NO - Delivery mode: Free delivery; CTI code: 114922-02 - Pack size: 3 x 12 ml - Commercialisation status: YES - CNK code: 0057448 - Delivery mode: Free delivery; CTI code: 114922-01 - Pack size: 12 ml - Commercialisation status: NO - CNK code: 0861674 - Delivery mode: Free delivery; CTI code: 114922-04 - Pack size: 50 x 12 ml - Commercialisation status: YES - CNK code: 1097906 - Delivery mode: Free delivery

authorization_status:

Commercialised: Yes

authorization_date:

1980-04-01